Literature DB >> 7523721

Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection Project.

C Mettlin1, G P Murphy, F Lee, P J Littrup, A Chesley, R Babaian, R Badalament, R A Kane, F K Mostofi.   

Abstract

The American Cancer Society-National Prostate Cancer Detection Project is a prospective, comparative study of a cohort of 2,999 men 55 to 70 years old not suspected on entry of having prostate cancer. A total of 164 prostate cancers is available from this project for analysis. A small proportion of tumors detected were advanced in terms of the clinical stage at diagnosis. Cancer detected by digital rectal examination tended to be more advanced than that found on the basis of only transrectal ultrasound or prostate specific antigen (PSA). A large proportion of patients received curative therapy involving radical prostatectomy in 67.1% and radiotherapy in 18.3%. Of 103 men presumed to have organ confined disease and treated by prostatectomy 64 (37.9%) actually had locally extensive cancer pathologically. PSA level and PSA density were associated with the detection of organ confined cancer but several advanced tumors had PSA levels in the normal range. Age referenced PSA, compared to conventional standards, demonstrated lower sensitivity to cancer with little improvement in specificity. The disease resulting from this multimodality detection effort represented a spectrum of pathological conditions. Further followup and evaluation are needed to determine whether these benefits are reflected in long-term mortality and survival experience.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523721     DOI: 10.1016/s0022-5347(17)32373-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Correlation of digital rectal examination, prostate specific antigen, and transrectal ultrasound in prostate carcinoma in African Americans.

Authors:  R I Sibley; A F Sibley
Journal:  J Natl Med Assoc       Date:  1997-05       Impact factor: 1.798

2.  Radiation therapy after radical prostatectomy: strike early, strike hard! The case for adjuvant radiation therapy.

Authors:  Dov Kadmon
Journal:  Rev Urol       Date:  2002

Review 3.  Stage T1c prostate cancer: defining the appropriate staging evaluation and the role for pelvic lymphadenectomy.

Authors:  M C Beduschi; R Beduschi; J E Oesterling
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

4.  The clinical value of the ratio of free prostate specific antigen to total prostate specific antigen.

Authors:  I Dalva; H Akan; O Yildiz; C Telli; N Bingol
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

5.  Prostate-specific antigen density--a reliable parameter for the detection of prostate cancer?

Authors:  W F Thon; F Gadban; M C Truss; M Kuczyk; U Hartmann; U Jonas
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

6.  Comparison of T1c versus T2 prostate cancers in Japanese patients undergoing radical prostatectomy.

Authors:  Y Furuya; S Ohta; N Sato; T Kotake; M Masai
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 7.  Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.

Authors:  Alexander Haese; Markus Graefen; Hartwig Huland; Hans Lilja
Journal:  Curr Urol Rep       Date:  2004-06       Impact factor: 3.092

8.  Unraveling Brazilian Indian population prostate good health: clinical, anthropometric and genetic features.

Authors:  Mario M de Lima Junior; Leonardo O Reis; Ubirajara Ferreira; Ulieme Oliveira Cardoso; Raquel Bueno Barbieri; Gustavo B de Mendonça; Laura S Ward
Journal:  Int Braz J Urol       Date:  2015 Mar-Apr       Impact factor: 1.541

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.